Patents by Inventor Hee-Sook Choi

Hee-Sook Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DATA DRIVER DEVICE AND DISPLAY DEVICE FOR REDUCING POWER CONSUMPTION IN A CHARGE-SHARE OPERATION
    Publication number: 20110316901
    Abstract: A data driver device and a display device, in which the data driver device includes a plurality of data lines; a plurality of first charge-share switches connected between a share line and the plurality of data lines, respectively; and a plurality of second charge-share switches each connected between two adjacent data lines among the plurality of data lines.
    Type: Application
    Filed: September 7, 2011
    Publication date: December 29, 2011
    Inventors: Jun-Hong Park, Si-Wang Sung, Hee-Sook Choi
  • Data driver device and display device for reducing power consumption in a charge-share operation
    Patent number: 8031146
    Abstract: A data driver device and a display device, in which the data driver device includes a plurality of data lines; a plurality of first charge-share switches connected between a share line and the plurality of data lines, respectively; and a plurality of second charge-share switches each connected between two adjacent data lines among the plurality of data lines.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: October 4, 2011
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Jun-Hong Park, Si-Wang Sung, Hee-Sook Choi
  • IL-32 monoclonal antibodies and uses thereof
    Patent number: 7641904
    Abstract: The present invention provides monoclonal antibodies specific for interleukin-32 (IL-32, previously referred to as “natural killer cell transcript 4” or “NK4”) and hybridomas secreting monoclonal antibodies specific for IL-32. Also provided are diagnostic methods and kits (e.g., ELISA, Western blot, etc.) which utilize monoclonal antibodies specific for IL-32.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: January 5, 2010
    Assignee: Konkuk University Industrial Cooperation Corp.
    Inventors: Ki-Hong Kim, Jung-Hyun Shim, Min-chul Cho, Jung-Woo Kang, Hee-Sook Choi, Eun-Hee Seo, Eun-young Song, Hee-Gu Lee, Mi-Young Park, Do-Young Yoon
  • IL-32 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20080219995
    Abstract: The present invention provides monoclonal antibodies specific for interleukin-32 (IL-32, previously referred to as “natural killer cell transcript 4” or “NK4”) and hybridomas secreting monoclonal antibodies specific for IL-32. Also provided are diagnostic methods and kits (e.g., ELISA, Western blot, etc.) which utilize monoclonal antibodies specific for IL-32.
    Type: Application
    Filed: February 15, 2008
    Publication date: September 11, 2008
    Inventors: Ki-Hong Kim, Jung-Hyun Shim, Min-chul Cho, Jung-Woo Kang, Hee-Sook Choi, Eun-Hee Seo, Eun-young Song, Hee-Gu Lee, Mi-Young Park, Do-Young Yoon
  • DATA DRIVER DEVICE AND DISPLAY DEVICE FOR REDUCING POWER CONSUMPTION IN A CHARGE-SHARE OPERATION
    Publication number: 20080170057
    Abstract: A data driver device and a display device, in which the data driver device includes a plurality of data lines; a plurality of first charge-share switches connected between a share line and the plurality of data lines, respectively; and a plurality of second charge-share switches each connected between two adjacent data lines among the plurality of data lines.
    Type: Application
    Filed: July 27, 2007
    Publication date: July 17, 2008
    Inventors: Jun-Hong Park, Si-Wang Sung, Hee-Sook Choi
  • Anti-cancer compositions
    Patent number: 5891864
    Abstract: The present invention relates to an anti-cancer composition containing acridine derivatives and guanosine compounds. In the composition of the present invention, the acridine derivative and the guanosine compound are present in the weight ratio of 1:0.1-5.0, preferably 1:0.3-3.0 and more preferably 1:0.5-1.5. In the composition of the present invention, most preferably the acridine derivative is acriflavine neutral and the guanosine compound is guanosine hydrate. Although acridine derivatives and guanosine compounds used as an active ingredient in the present composition have substantially no anti-cancer effect when they are used individually, the combination of acriflavine neutral and guanosine hydrate which potentiates the effect of acriflavine neutral, i.e. the composition(AG60) according to the present invention, exhibits reduced toxicity and increased anti-cancer effect in comparison to the use of acriflavine neutral or guanosine hydrate alone.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: April 6, 1999
    Assignees: Yung Bok Han, Tae Rim Pharm. Co., Ltd.
    Inventors: Yung Bok Han, Hong Ki Kyung, Chun Won Kim, E Tay Ahn, Jong Bae Kim, Hyo Suk Lee, Kyung Yung Lee, Eun Kyung Hong, Hee Sook Choi, Sang Geon Kim, Bo Im Yoo, Hae Kyung Kwon